ストックスクリーナーアプリを入手
8.52
1.05%
-0.09
アフターアワーズ：
8.52
前日終値:
$8.61
開ける：
$8.56
24時間の取引高:
327.86K
Relative Volume:
1.10
時価総額：
$406.93M
収益：
$36.90M
当期純損益:
$-166.28M
株価収益率:
-2.5897
EPS:
-3.29
ネットキャッシュフロー:
$-203.53M
1週間 パフォーマンス:
+1.79%
1か月 パフォーマンス:
+17.68%
6か月 パフォーマンス:
-34.36%
1年 パフォーマンス:
-64.13%
1日の値動き範囲:
$8.40
$8.61
1週間の範囲:
$8.40
$9.01
52週間の値動き範囲:
$6.10
$28.67
Bicycle Therapeutics Plc Adr Stock (BCYC) Company Profile
名前
Bicycle Therapeutics Plc Adr
セクター
電話
011441223261503
住所
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE
BCYC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCYC
Bicycle Therapeutics Plc Adr
|
8.52 | 596.28M | 36.90M | -166.28M | -203.53M | -3.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicycle Therapeutics Plc Adr Stock (BCYC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | 開始されました | Stephens | Equal-Weight |
| 2024-09-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-07 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2023-09-11 | アップグレード | B. Riley Securities | Neutral → Buy |
| 2022-08-31 | 開始されました | Cowen | Outperform |
| 2022-07-28 | 開始されました | Barclays | Overweight |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-04-13 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-04-07 | 再開されました | Cantor Fitzgerald | Overweight |
| 2022-02-14 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 開始されました | SVB Leerink | Outperform |
| 2021-12-09 | 開始されました | Needham | Buy |
| 2021-09-30 | 開始されました | B. Riley Securities | Buy |
| 2021-04-20 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-10-12 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-06-12 | 開始されました | Oppenheimer | Outperform |
| 2020-04-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-14 | 開始されました | ROTH Capital | Buy |
| 2019-09-11 | アップグレード | Goldman | Neutral → Buy |
| 2019-06-17 | 開始されました | Canaccord Genuity | Buy |
| 2019-06-17 | 開始されました | Goldman | Neutral |
| 2019-06-17 | 開始されました | Jefferies | Buy |
| 2019-06-17 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Bicycle Therapeutics Plc Adr (BCYC) 最新ニュース
Coursera (NYSE:COUR) Sees Strong Trading Volume on Analyst Upgrade - Defense World
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Teacher Retirement System of Texas - Defense World
Principal Financial Group Inc. Boosts Stock Position in Schneider National, Inc. (NYSE:SNDR) - Defense World
Principal Financial Group Inc. Purchases 1,695 Shares of Monarch Casino & Resort, Inc. (NASDAQ:MCRI) - Defense World
Teacher Retirement System of Texas Has $465,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World
Teacher Retirement System of Texas Sells 1,266 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World
Teacher Retirement System of Texas Has $534,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
William Blair Brokers Decrease Earnings Estimates for TLX - Defense World
Principal Financial Group Inc. Purchases 5,315 Shares of Aaron’s Holdings Company, Inc. (NYSE:PRG) - Defense World
First Northwest Bancorp (FNWB) Expected to Announce Quarterly Earnings on Thursday - Defense World
Principal Financial Group Inc. Acquires 17,237 Shares of Upbound Group, Inc. (NASDAQ:UPBD) - Defense World
The Bank of Nova Scotia (TSE:BNS) Receives Average Rating of “Hold” from Analysts - Defense World
Bicycle Therapeutics (NASDAQ:BCYC) Shares Gap Up – Should You Buy? - Defense World
Bicycle Therapeutics’ SWOT analysis: stock faces pivotal phase amid clinical progress - Investing.com India
Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 7.40 - DWinneX
Bicycle Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com South Africa
How should investors view Bicycle Therapeutics Plc ADR (BCYC)? - uspostnews.com
PBF Energy Inc [PBF] Records 50-Day SMA of $19.79 - knoxdaily.com
UGI Corp [UGI] Records 200-Day SMA of $27.63 - knoxdaily.com
Cellebrite DI Ltd [NASDAQ: CLBT] Sees Increase in Stock Value - knoxdaily.com
Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.69 % on Wednesday - knoxdaily.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading - MSN
Bicycle Therapeutics Plc ADR Inc. (BCYC) Price Performance: The Role of Supply and Demand - investchronicle.com
Fastenal Co (FAST) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Bicycle therapeutics CFO Alethia Young sells $1,724 in stock By Investing.com - Investing.com India
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292 By Investing.com - Investing.com South Africa
Bicycle therapeutics COO Alistair Milnes sells $16,850 in stock By Investing.com - Investing.com South Africa
Bicycle Therapeutics chief product officer sells shares worth $5,735 - Investing.com
Bicycle Therapeutics CEO Lee Kevin sells shares worth $43,612 - Investing.com
Bicycle Therapeutics chief accounting officer sells shares worth $2,499 - Investing.com
Bicycle therapeutics CFO Alethia Young sells $1,724 in stock - Investing.com
Bicycle therapeutics CTO Michael Skynner sells shares worth $14,292 - Investing.com
Bicycle Therapeutics chief accounting officer sells shares worth $2,499 By Investing.com - Investing.com UK
Bicycle Therapeutics stock hits 52-week low at $8.6 amid downturn By Investing.com - Investing.com South Africa
Bicycle Therapeutics reshuffles leadership, aims for oncology advances By Investing.com - Investing.com South Africa
Bicycle Therapeutics reshuffles leadership, aims for oncology advances - Investing.com India
Bicycle Therapeutics stock hits 52-week low at $8.98 By Investing.com - Investing.com South Africa
Bicycle Therapeutics’ SWOT analysis: innovative platform drives stock potential - Investing.com India
Advanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.
Jefferies cuts Bicycle Therapeutics price target to $42 from $53 By Investing.com - Investing.com South Africa
Bicycle Therapeutics stock holds $33 target, Buy rating at Rodman By Investing.com - Investing.com South Africa
Mizuho maintains Harmony Biosciences $42 target, Outperform rating - Investing.com India
Mizuho maintains Harmony Biosciences $42 target, Outperform rating By Investing.com - Investing.com South Africa
Bicycle Therapeutics' SWOT analysis: platform potential drives stock outlook - Investing.com
Bicycle Therapeutics reports promising cancer drug trial results - Investing.com
Bicycle Therapeutics exec sells $30k in shares - Investing.com
Bicycle Therapeutics spotlights cancer treatment targets - Investing.com
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Oppenheimer backs Bicycle Therapeutics' BRC platform, reiterates $48 stock PT - Investing.com UK
Bicycle therapeutics CEO sells shares worth over $71k - Investing.com
South Korea Peptide Drug Conjugates Market Size & Outlook, 2030 - Grand View Research
Bicycle Therapeutics Plc Adr (BCYC) 財務データ
収益
当期純利益
現金流量
EPS
10.28%
2.59%
大文字化:
|
ボリューム (24 時間):